Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens
A study evaluating a single-use point-of-care diagnostic device for detecting multiple respiratory pathogens was terminated, with results po…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine [Phase 1, Phase 2]
This notice reports that Sinocelltech Ltd. is conducting a Phase 1/2 trial to evaluate the safety, tolerability, and immunogenicity of a rec…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. [Phase 3]
Pfizer's RSVpreF Phase 3 trial evaluating efficacy and safety in infants born to women vaccinated during pregnancy has completed and posted …
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers [Phase 1]
A Phase 1 inpatient RSV challenge trial in healthy adult volunteers using the rRSV A/Maryland/001/11 strain, with status noted as completed.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children [Phase 1]
Phase 1 clinical trial evaluating the safety and immunogenicity of CodaVax-RSV in seropositive and seronegative children; trial is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of the monoclonal antibody Clesrovimab (MK-1654) for respiratory syncyti…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
An observational study of Moderna's RSV vaccine candidate mRNA-1345 has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections [NA]
Clinical trial update on the efficacy of LiveSpo Navax as supportive treatment for pneumonia in children with RSV and bacterial co-infection…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: The Effect of Sevoflurane on Airway Hyperreactivity During the Perioperative Period.
A clinical trial evaluated whether sevoflurane influences airway hyperreactivity during the perioperative period in children with RSV infect…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: COMMUNITY - the COVID-19 Immunity Study
A Clinical Trials update indicates that the COMMUNITY COVID-19 Immunity Study is currently recruiting at Danderyd Hospital. The study appear…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate the effectiveness and safety of AK0529 for treating respiratory syncytial virus infection…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Universal Anti-Viral Vaccine for Healthy Elderly Adults [Phase 1, Phase 2]
Phase 1/2 trial of a universal antiviral vaccine for healthy elderly adults has completed, evaluating safety across multiple viral infection…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
A completed prospective observational study examining how mucosal immunity influences infectious viral load in SARS-CoV-2, influenza, and RS…
-
CLINICAL_TRIALS withdrawal · 2024-12-31Clinical Trial Update: Safety and Immunogenicity Study of SCB-1019T in Children [Phase 1]
A Phase 1 safety and immunogenicity trial of SCB-1019T for respiratory syncytial virus infection in children has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). [Phase 2]
Pfizer completed a Phase 2 trial evaluating a single-shot combination vaccine for COVID-19 and Respiratory Syncytial Virus (RSV); results ha…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Cell Mediated Immunity Against RSV and Influenza in a Human Experimental Challenge [NA]
This completed Imperial College London clinical study assessed cell-mediated immune responses to respiratory syncytial virus infection and i…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: RSV Vaccination in Immunocompromised Patients. [Phase 2]
A Phase 2 clinical trial evaluating an RSV vaccine in immunocompromised patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults [Phase 1]
Pfizer completed a Phase 1 study of a respiratory combination vaccine targeting respiratory syncytial virus and influenza in healthy older a…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients [NA]
Multi-site clinical evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 diagnostic assay in symptomatic patients; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: MVA-BN-RSV Vaccine Trial [Phase 3]
Phase 3 trial of Bavarian Nordic's MVA-BN-RSV vaccine was terminated, with results posted on 2024-10-31.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. [Phase 2]
Pfizer's Phase 2 trial of sisunatovir in infants with respiratory syncytial virus lower respiratory tract infection has been terminated, wit…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV) [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, and antiviral activity of RV299 against Respiratory Syncytial Virus. The trial is complet…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Safety and Efficacy of BARS13 in the Elderly [Phase 2]
Phase 2 trial evaluating the safety and efficacy of BARS13 in elderly participants with respiratory syncytial virus infections has completed…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants [Phase 1]
Pfizer completed a Phase 1 trial evaluating the safety, effects and palatability of Sisunatovir in healthy adults, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Development of a Human Model of Respiratory Syncytial Virus Infection [NA]
This clinical trial update describes the development of a human model of Respiratory syncytial virus infection; the trial is completed and r…